German filling and packaging technology manufacturer Krones has closed the transaction to buy US-based firm WM Sprinkman.

Sprinkman was established in 1929 and provides engineered food and beverage processing equipment.

With revenues of around $35m, the company is specialised in supplying equipment and processes for customers in the dairy and brewing industries. It operates two facilities in Waukesha and Elroy, Wisconsin, and employs more than 125 workers.

Customers of the company include microbreweries, as well as multi-national food and beverage producers.

The acquisition will enable Krones to enhance the capabilities of its ‘House of Krones’ product portfolio in North America, which includes process technology solutions, bottling, and packaging equipment.

Other services offered under the portfolio include intralogistics, IT solutions, plastics recycling, and entire lifecycle service support.

“We now have a synergistic offering in processing solutions, and can additionally supply Sprinkman’s customer base with the automation tools they need.”

Krones president and CEO Holger Beckmann said: “Bringing Sprinkman into the Krones family not only adds an experienced team of employees and a great customer base, but also helps round out our US-based process engineering and manufacturing capabilities.

“Combined with the strength of our subsidiaries Trans-Market and Javlyn Process Systems, we now have a synergistic offering in processing solutions, and can additionally supply Sprinkman’s customer base with the automation tools they need to gain competitive edge in the marketplace through our subsidiary, Process and Data Automation.”

Sprinkman will become a subsidiary of Krones Group and continue its operations at its two facilities in Wisconsin.

Last month, Krones acquired Chinese firm Shanghai Xiantong Equipment Installation to boost its process technology portfolio.

Free Whitepaper How electronic inspection sensors prevented a potentially extremely costly product recall

A pharmaceutical client was at risk of a product recall due to a capping problem with a new tablet formulation. This document explains how DJA Pharma prevented a costly recall with a simple, elegant and effective solution.

Enter your details here to receive your free whitepaper.

Machinery whitepaper

Download our whitepaper

Yes I have read and accept the terms and conditions and privacy policys.


You are in control of the communications you receive from us and you can update your preferences anytime to make sure you are receiving information that matters to you. Please check our Verdict Privacy Policy to see how we protect and manage your submitted data.

You will receive your free whitepaper after you submit the form.

Close